Paul Campanelli Insider Trading Transactions
Get free email notifications about insider trading for Paul Campanelli.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Campanelli. Paul Campanelli is Chief Executive Officer in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Chief Operating Officer in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Par Pharmaceutical in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres. - Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres. Generic Prod Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres.-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, President-Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP; President - Generics in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres Generic Prod Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres Generics Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres-Generics Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Director in Endo International plc ($ENDP) and Group President, Generics in Endo International plc ($ENDP) and President & CEO in Endo International plc ($ENDP) and President, CEO in Endo International plc ($ENDP) and President, Par Pharmaceutical in Endo International plc ($ENDP).
Latest Insider Trading Transactions of Paul Campanelli
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.76 | 700 | 21,534 | 141,331 | 142 K to 141.3 K (-0.49 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.76 | 4,500 | 138,420 | 142,031 | 146.5 K to 142 K (-3.07 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.76 | 2,300 | 70,737 | 146,531 | 148.8 K to 146.5 K (-1.55 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.75 | 75,400 | 2,318,550 | 148,831 | 224.2 K to 148.8 K (-33.63 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.68 | 1,000 | 30,680 | 224,231 | 225.2 K to 224.2 K (-0.44 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.68 | 400 | 12,270 | 225,231 | 225.6 K to 225.2 K (-0.18 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.67 | 1,600 | 49,072 | 225,631 | 227.2 K to 225.6 K (-0.70 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.66 | 300 | 9,198 | 227,231 | 227.5 K to 227.2 K (-0.13 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Sell | S | 30.65 | 746 | 22,865 | 227,531 | 228.3 K to 227.5 K (-0.33 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Buy | M | 13.06 | 24,855 | 324,606 | 228,277 | 203.4 K to 228.3 K (+12.22 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Buy | M | 28.79 | 7,500 | 215,925 | 203,392 | 195.9 K to 203.4 K (+3.83 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Buy | M | 27.71 | 5,864 | 162,491 | 195,892 | 190 K to 195.9 K (+3.09 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Buy | M | 10.99 | 68,591 | 753,815 | 190,028 | 121.4 K to 190 K (+56.48 %) |
Mar 09 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Buy | M | 24.27 | 9,525 | 231,172 | 121,437 | 111.9 K to 121.4 K (+8.51 %) |
Jan 13 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Payment of Exercise | F | 35.98 | 21,348 | 768,101 | 111,888 | 133.2 K to 111.9 K (-16.02 %) |
Jan 13 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Grant | A | 0.00 | 21,603 | 0 | 133,236 | 111.6 K to 133.2 K (+19.35 %) |
Jan 10 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Option Exercise | A | 36.54 | 17,740 | 648,220 | 17,740 | |
Jan 10 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Grant | A | 0.00 | 8,870 | 0 | 111,633 | 102.8 K to 111.6 K (+8.63 %) |
Jan 06 2011 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Payment of Exercise | F | 37.79 | 1,062 | 40,133 | 102,763 | 103.8 K to 102.8 K (-1.02 %) |
Dec 22 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 38.26 | 2,496 | 95,497 | 103,825 | 106.3 K to 103.8 K (-2.35 %) |
Nov 19 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Par Pharm ... | Payment of Exercise | F | 37.72 | 14,019 | 528,797 | 106,321 | 120.3 K to 106.3 K (-11.65 %) |
Mar 24 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 25.09 | 2,200 | 55,198 | 120,340 | 122.5 K to 120.3 K (-1.80 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Option Exercise | M | 13.06 | 24,885 | 324,998 | 74,656 | |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.13 | 100 | 2,513 | 122,540 | 122.6 K to 122.5 K (-0.08 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.12 | 300 | 7,536 | 122,640 | 122.9 K to 122.6 K (-0.24 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.11 | 4,800 | 120,528 | 122,940 | 127.7 K to 122.9 K (-3.76 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.10 | 200 | 5,020 | 127,740 | 127.9 K to 127.7 K (-0.16 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.09 | 200 | 5,018 | 127,940 | 128.1 K to 127.9 K (-0.16 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.08 | 100 | 2,508 | 128,140 | 128.2 K to 128.1 K (-0.08 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.08 | 600 | 15,045 | 128,240 | 128.8 K to 128.2 K (-0.47 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.07 | 500 | 12,535 | 128,840 | 129.3 K to 128.8 K (-0.39 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.06 | 100 | 2,506 | 129,340 | 129.4 K to 129.3 K (-0.08 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.06 | 3,600 | 90,216 | 129,440 | 133 K to 129.4 K (-2.71 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.05 | 700 | 17,535 | 133,040 | 133.7 K to 133 K (-0.52 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.04 | 300 | 7,512 | 133,740 | 134 K to 133.7 K (-0.22 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.03 | 100 | 2,503 | 134,040 | 134.1 K to 134 K (-0.07 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.02 | 200 | 5,004 | 134,140 | 134.3 K to 134.1 K (-0.15 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.01 | 600 | 15,006 | 134,340 | 134.9 K to 134.3 K (-0.44 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Sell | S | 25.00 | 12,485 | 312,125 | 134,940 | 147.4 K to 134.9 K (-8.47 %) |
Mar 03 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP; President - Ge ... | Buy | M | 13.06 | 24,885 | 324,998 | 147,425 | 122.5 K to 147.4 K (+20.31 %) |
Jan 12 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 25.80 | 1,017 | 26,239 | 122,540 | 123.6 K to 122.5 K (-0.82 %) |
Jan 12 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 25.80 | 1,509 | 38,932 | 123,557 | 125.1 K to 123.6 K (-1.21 %) |
Jan 06 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Option Exercise | A | 27.71 | 23,457 | 649,993 | 23,457 | |
Jan 06 2010 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Grant | A | 0.00 | 11,729 | 0 | 125,066 | 113.3 K to 125.1 K (+10.35 %) |
Dec 22 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 26.04 | 1,807 | 47,054 | 113,337 | 115.1 K to 113.3 K (-1.57 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.37 | 300 | 6,111 | 115,144 | 115.4 K to 115.1 K (-0.26 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.35 | 400 | 8,140 | 115,444 | 115.8 K to 115.4 K (-0.35 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.33 | 5,105 | 103,785 | 115,844 | 120.9 K to 115.8 K (-4.22 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.32 | 900 | 18,288 | 120,949 | 121.8 K to 120.9 K (-0.74 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.31 | 500 | 10,155 | 121,849 | 122.3 K to 121.8 K (-0.41 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.30 | 100 | 2,030 | 122,349 | 122.4 K to 122.3 K (-0.08 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.28 | 300 | 6,084 | 122,449 | 122.7 K to 122.4 K (-0.24 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.27 | 1,100 | 22,297 | 122,749 | 123.8 K to 122.7 K (-0.89 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.26 | 300 | 6,078 | 123,849 | 124.1 K to 123.8 K (-0.24 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.25 | 4,869 | 98,597 | 124,149 | 129 K to 124.1 K (-3.77 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.24 | 4,700 | 95,128 | 129,018 | 133.7 K to 129 K (-3.51 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.23 | 700 | 14,161 | 133,418 | 134.1 K to 133.4 K (-0.52 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.21 | 2,300 | 46,483 | 134,418 | 136.7 K to 134.4 K (-1.68 %) |
Aug 26 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. - Generi ... | Sell | S | 20.20 | 9,660 | 195,132 | 136,718 | 146.4 K to 136.7 K (-6.60 %) |
Mar 24 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 11.19 | 2,200 | 24,618 | 146,378 | 148.6 K to 146.4 K (-1.48 %) |
Jan 14 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres-Generics | Payment of Exercise | F | 12.59 | 1,107 | 13,937 | 148,578 | 149.7 K to 148.6 K (-0.74 %) |
Jan 12 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres.-Generics | Option Exercise | A | 13.06 | 99,541 | 1,300,005 | 99,541 | |
Jan 12 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres.-Generics | Payment of Exercise | F | 12.83 | 1,789 | 22,953 | 149,595 | 151.4 K to 149.6 K (-1.18 %) |
Jan 12 2009 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres.-Generics | Grant | A | 13.59 | 1,044 | 14,188 | 151,384 | 152.4 K to 151.4 K (-0.68 %) |
Dec 23 2008 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres.-Generics | Payment of Exercise | F | 12.43 | 1,807 | 22,461 | 152,428 | 150.6 K to 152.4 K (+1.20 %) |
Nov 20 2008 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, President-Gene ... | Option Exercise | A | 10.99 | 102,881 | 1,130,662 | 102,881 | |
Nov 20 2008 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, President-Gene ... | Grant | A | 0.00 | 45,496 | 0 | 154,235 | 108.7 K to 154.2 K (+41.84 %) |
Mar 26 2008 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | EVP, Pres. Generic ... | Payment of Exercise | F | 18.37 | 2,200 | 40,414 | 108,739 | 110.9 K to 108.7 K (-1.98 %) |
Jan 15 2008 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Exec VP, Pres Gener ... | Grant | A | 0.00 | 36,849 | 0 | 110,579 | 73.7 K to 110.6 K (+49.98 %) |
Oct 03 2007 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Exec VP, Pres-Gener ... | Buy | P | 18.19 | 2,100 | 38,199 | 11,874 | 9.8 K to 11.9 K (+21.49 %) |
Mar 26 2007 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Exec VP, Pres Gener ... | Option Exercise | A | 24.27 | 12,700 | 308,229 | 12,700 | |
Mar 26 2007 | PRX | PAR PHARMACEUTICAL ... | Campanelli Paul | Exec VP, Pres Gener ... | Grant | A | 0.00 | 26,300 | 0 | 54,870 | 28.6 K to 54.9 K (+92.05 %) |